Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 509

1.

A unified Hyperglycemia and Diabetic ketoacidosis (DKA) insulin infusion protocol based on an Excel algorithm and implemented via Electronic Medical Record (EMR) in Intensive Care Units.

Gupta D, Kirn M, Jamkhana ZA, Lee R, Albert SG.

Diabetes Metab Syndr. 2016 Sep 15. pii: S1871-4021(16)30204-1. doi: 10.1016/j.dsx.2016.09.008. [Epub ahead of print]

PMID:
27658894
2.

Critical Care Glucose Point-of-Care Testing.

Narla SN, Jones M, Hermayer KL, Zhu Y.

Adv Clin Chem. 2016;76:97-121. doi: 10.1016/bs.acc.2016.05.002. Epub 2016 Jun 14.

PMID:
27645817
3.

Medication-induced and spontaneous hypoglycemia carry the same risk for hospital mortality in critically ill patients.

Saliba L, Cook CH, Dungan KM, Porter K, Murphy CV.

J Crit Care. 2016 Jun 23;36:13-17. doi: 10.1016/j.jcrc.2016.06.010. [Epub ahead of print]

PMID:
27546741
4.

Methimazole-induced insulin autoimmune syndrome.

Jain N, Savani M, Agarwal M, Kadaria D.

Ther Adv Endocrinol Metab. 2016 Aug;7(4):178-81. doi: 10.1177/2042018816658396. Epub 2016 Jul 19. Review.

5.

Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.

Kar P, Plummer MP, Bellomo R, Jenkins AJ, Januszewski AS, Chapman MJ, Jones KL, Horowitz M, Deane AM.

Crit Care Med. 2016 Sep;44(9):1695-703. doi: 10.1097/CCM.0000000000001815.

PMID:
27315191
6.

Minimization of Hypoglycemia as an Adverse Event During Insulin Infusion: Further Refinement of the Yale Protocol.

Marvin MR, Inzucchi SE, Besterman BJ.

Diabetes Technol Ther. 2016 Aug;18(8):480-6. doi: 10.1089/dia.2016.0101. Epub 2016 Jun 3.

7.

Neuroglucopenia and Metabolic Distress in Two Patients with Viral Meningoencephalitis: A Microdialysis Study.

Kofler M, Schiefecker A, Beer R, Sohm F, Broessner G, Rhomberg P, Lackner P, Pfausler B, Thomé C, Schmutzhard E, Helbok R.

Neurocrit Care. 2016 Apr 25. [Epub ahead of print]

PMID:
27112148
8.

Predisposing Factors for Hypoglycemia and Its Relation With Mortality in Critically Ill Patients Undergoing Insulin Therapy in an Intensive Care Unit.

Mahmoodpoor A, Hamishehkar H, Beigmohammadi M, Sanaie S, Shadvar K, Soleimanpour H, Rahimi A, Safari S.

Anesth Pain Med. 2016 Jan 31;6(1):e33849. doi: 10.5812/aapm.33849. eCollection 2016 Feb.

9.

PREVENTION AND MANAGEMENT OF INSULIN-ASSOCIATED HYPOGLYCEMIA IN HOSPITALIZED PATIENTS.

Mathioudakis N, Everett E, Golden SH.

Endocr Pract. 2016 Aug;22(8):959-69. doi: 10.4158/EP151119.OR. Epub 2016 Apr 4.

PMID:
27042740
10.

Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis.

Stewart KW, Pretty CG, Tomlinson H, Thomas FL, Homlok J, Noémi SN, Illyés A, Shaw GM, Benyó B, Chase JG.

Ann Intensive Care. 2016 Dec;6(1):24. doi: 10.1186/s13613-016-0125-9. Epub 2016 Mar 29.

11.

Transition From Intravenous to Subcutaneous Insulin in Critically Ill Adults.

Doolin MK, Walroth TA, Harris SA, Whitten JA, Fritschle-Hilliard AC.

J Diabetes Sci Technol. 2016 Jun 28;10(4):932-8. doi: 10.1177/1932296816629985. Print 2016 Jul.

PMID:
26908569
12.

Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.

Rodriguez-Gutierrez R, Lipska KJ, McCoy RG.

JAMA Intern Med. 2016 Mar;176(3):300-1. doi: 10.1001/jamainternmed.2015.8320. No abstract available.

PMID:
26882223
13.

Glucose control in acute brain injury: does it matter?

Godoy DA, Behrouz R, Di Napoli M.

Curr Opin Crit Care. 2016 Apr;22(2):120-7. doi: 10.1097/MCC.0000000000000292.

PMID:
26866521
14.

Space GlucoseControl system for blood glucose control in intensive care patients--a European multicentre observational study.

Blaha J, Barteczko-Grajek B, Berezowicz P, Charvat J, Chvojka J, Grau T, Holmgren J, Jaschinski U, Kopecky P, Manak J, Moehl M, Paddle J, Pasculli M, Petersson J, Petros S, Radrizzani D, Singh V, Starkopf J.

BMC Anesthesiol. 2016 Jan 22;16:8. doi: 10.1186/s12871-016-0175-4.

15.

Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.

Rodbard D.

Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S23-213. doi: 10.1089/dia.2015.0417.

16.

Development of a Screening Tool for Predicting Adverse Outcomes of Gestational Diabetes Mellitus: A Retrospective Cohort Study.

Park JS, Kim DW, Kwon JY, Park YW, Kim YH, Cho HY.

Medicine (Baltimore). 2016 Jan;95(1):e2204. doi: 10.1097/MD.0000000000002204.

17.

Metabolic Management during Critical Illness: Glycemic Control in the ICU.

Honiden S, Inzucchi SE.

Semin Respir Crit Care Med. 2015 Dec;36(6):859-69. doi: 10.1055/s-0035-1565253. Epub 2015 Nov 23. Review.

PMID:
26595046
18.

Evaluation of the treatment of diabetic ketoacidosis in the medical intensive care unit.

Fusco N, Gonzales J, Yeung SY.

Am J Health Syst Pharm. 2015 Dec 1;72(23 Suppl 3):S177-82. doi: 10.2146/sp150028.

PMID:
26582306
19.

Higher insulin infusion rate but not 24-h insulin consumption is associated with hypoglycemia in critically ill patients.

Radosevich JJ, Patanwala AE, Frey PD, Lee YG, Paddock H, Erstad BL.

Diabetes Res Clin Pract. 2015 Dec;110(3):322-7. doi: 10.1016/j.diabres.2015.09.018. Epub 2015 Oct 9.

PMID:
26489824
20.

Prevalence and Impact of Unknown Diabetes in the ICU.

Carpenter DL, Gregg SR, Xu K, Buchman TG, Coopersmith CM.

Crit Care Med. 2015 Dec;43(12):e541-50. doi: 10.1097/CCM.0000000000001353.

PMID:
26465219
Items per page

Supplemental Content

Loading ...
Write to the Help Desk